Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GOSS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
27 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
169 filers reported a long position in GOSS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | $6.7M | 41M | +10,417.7% |
| 683 Capital Management, LLC | $6.5M | 39.2M | +684% |
| DeepCurrents Investment Group LLC | $6M | 37.7M | New |
| Context Capital Management, LLC | $4.8M | 28.9M | New |
| Worth Venture Partners, LLC | $4.1M | 25M | New |
| AQR CAPITAL MANAGEMENT LLC | $2.6M | 15.6M | +54.3% |
| GSA CAPITAL PARTNERS LLP | $2.5M | 15M | +360.5% |
| WOLVERINE ASSET MANAGEMENT LLC | $2.1M | 12.9M | New |
| RENAISSANCE TECHNOLOGIES LLC | $1.9M | 11.6M | +854.9% |
| Kalehua Capital Management LLC | $1.8M | 11.1M | +8.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.